The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed to those with Type 2 diabetes, it is also used for weight loss.

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Rocketing demand, legal disputes, and the future of weight loss were all spurred by a new class of anti-obesity medications.

US-based pharmaceutical company Eli Lilly is planning to launch Mounjaro, an anti-diabetes and weight loss ... a prescription-based medication that has to be injected once a week.

Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk.

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

For example, there are significant differences in how well people respond to anti-obesity or anti-diabetes drugs, and we hope ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

This led them to the conclusion that antibiotics, antivirals and anti-inflammatory drugs were all associated with reduced ...